UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 8, 2021

Accession Number:	0001564590-21-011275
Submission Type:	POS AM
CIK: 0001738021 Company Name: Compass Therapeutics, Inc. File Number: 333-244353